|
시장보고서
상품코드
1747282
세계의 환자 지원 프로그램(PSP) 시장 : 서비스 유형별, 치료 영역별, 연령층별, 제공 형태별, 성별, 최종사용자별, 지역별Patient Support Programs (PSP) Market, By Service Type, By Therapeutic Area, By Age Group, By Delivery Mode, By Gender, By End User, By Geography |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세계의 환자 지원 프로그램(PSP) 시장은 2025년에 227억 달러, 2032년에는 689억 5,000만 달러에 이르고, 2025-2032년 연평균 복합 성장률(CAGR)은 17.2%를 보일 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024 | 2025년 시장 규모 | 227억 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측 기간(2025-2032년) CAGR | 17.20% | 2032년 가치 예측 | 689억 5,000만 달러 |
환자 지원 프로그램(PSP)은 헬스케어 업계에서 환자와 처방된 치료 사이의 간극을 메우는 중요한 요소로 부상하고 있습니다. PSP는 환자가 복잡한 의료 시스템을 이용하고, 의약품에 접근하고, 치료 계획을 준수할 수 있도록 종합적인 지원을 제공하도록 설계되었으며, PSP에는 재정적 지원, 교육적 자원, 정신적 지원, 치료 조정 등 다양한 서비스가 포함됩니다. 포함합니다. PSP는 환자가 직면한 고유한 요구와 과제를 해결함으로써 환자의 예후를 개선하고, 삶의 질을 향상시키며, 만성적이고 생명을 위협하는 증상에 대한 부담을 경감시키는 것을 목표로 합니다. 헬스케어 환경이 계속 변화함에 따라 환자 중심의 접근 방식과 개별화된 지원에 대한 수요가 크게 증가하면서 전 세계 환자 지원 프로그램 시장의 성장을 주도하고 있습니다.
시장 역학:.
세계 환자 지원 프로그램 시장의 성장은 만성질환의 유병률 증가, 의료비 증가, 환자 중심 치료에 대한 수요 증가 등 몇 가지 중요한 요인에 의해 주도되고 있습니다. 당뇨병, 심혈관 질환, 암과 같은 만성 질환의 부담은 전 세계적으로 꾸준히 증가하고 있으며, 환자의 상태를 효과적으로 관리하기 위한 종합적인 지원 서비스가 필요합니다. PSP는 지원 프로그램, 본인부담금 지원 및 기타 재정적 지원을 제공함으로써 이러한 경제적 장벽을 낮추는 데 중요한 역할을 하고 있습니다. 또한, 환자 중심 치료 모델로의 전환은 개별화된 지원과 참여의 중요성을 강조하며, 환자 개개인의 필요에 맞게 서비스를 조정할 수 있는 PSP에 대한 수요를 촉진하고 있습니다.
그러나 PSP 도입 및 관리의 복잡성, 데이터 프라이버시 문제, 규제 문제 등 시장에는 일정한 제약 요인이 존재합니다. 의료 서비스 제공업체, 지불자, 제약사 등 다양한 이해관계자간의 원활한 협력이 필요하기 때문에 운영이 어려울 수 있습니다. 또한, 환자 데이터를 보호하고 진화하는 의료 규제를 준수하기 위해서는 견고한 보안 조치와 지속적인 적응이 필요합니다.
본 조사의 주요 특징
- 세계의 환자 지원 프로그램(PSP) 시장을 상세하게 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(10억 달러)와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
- 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
- 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 환자 지원 프로그램(PSP) 시장의 주요 기업을 프로파일링합니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 환자 지원 프로그램(PSP) 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 환자 지원 프로그램(PSP) 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 발매/승인
- PEST 분석
- PORTER 분석
- 인수합병(M&A) 시나리오
- 업계 동향
제4장 세계의 환자 지원 프로그램(PSP) 시장, 서비스 유형별, 2020년-2032년
- 복약 준수 지원
- 환자 교육 및 카운셀링
- 질환 특이적 케어 코디네이션
- 재정 원조 및 환불
- 기타
제5장 세계의 환자 지원 프로그램(PSP) 시장, 치료 영역별, 2020년-2032년
- 종양학
- 심장병학
- 신경학
- 면역학
- 류머티즘학
- 기타(당뇨병 및 감염증)
제6장 세계의 환자 지원 프로그램(PSP) 시장, 연령 그룹별, 2020년-2032년
- 소아
- 성인
- 고령자
제7장 세계의 환자 지원 프로그램(PSP) 시장, 제공 형태별, 2020년-2032년
- 대면 서비스
- 디지털 솔루션
- 하이브리드 모델
제8장 세계의 환자 지원 프로그램(PSP) 시장, 성별, 2020년-2032년
- 남성
- 여성
제9장 세계의 환자 지원 프로그램(PSP) 시장, 최종사용자별, 2020년-2032년
- 제약회사
- 바이오테크놀러지 기업
- 의료기기 기업
- 요양시설
- 의료 제공자
- 기타(연구센터 등)
제10장 세계의 환자 지원 프로그램(PSP) 시장, 지역별, 2020년-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙아프리카
제11장 경쟁 구도
- Roche
- Novartis
- Pfizer
- Merck & Co.
- Johnson & Johnson
- Sanofi
- AstraZeneca
- GSK(GlaxoSmithKline)
- AbbVie
- Amgen
- Bayer
- Eli Lilly and Company
- Bristol-Myers Squibb
- Takeda Pharmaceutical Company
- Biogen
제12장 애널리스트 추천 사항
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map
제13장 참고 문헌과 조사 방법
- 참고 문헌
- 조사 방법
- 출판사에 대해
The Global Patient Support Programs (PSP) Market is estimated to be valued at USD 22.70 Bn in 2025 and is expected to reach USD 68.95 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 17.2% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 22.70 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 17.20% | 2032 Value Projection: | USD 68.95 Bn |
Patient Support Programs (PSPs) have emerged as a crucial component in the healthcare industry, bridging the gap between patients and their prescribed treatments. These programs are designed to provide comprehensive assistance to patients, enabling them to navigate the complexities of healthcare systems, access medications, and adhere to their treatment plans. PSPs encompass a wide range of services, including financial assistance, educational resources, emotional support, and care coordination. By addressing the unique needs and challenges faced by patients, PSPs aim to improve patient outcomes, enhance the quality of life, and reduce the burden of chronic and life-altering conditions. As the healthcare landscape continues to evolve, the demand for patient-centric approaches and personalized support has grown significantly, driving the expansion of the global patient support programs market.
Market Dynamic:
The global patient support programs market growth is driven by several key factors, including the rising prevalence of chronic diseases, increasing healthcare costs, and the growing need for patient-centric care. The burden of chronic conditions, such as diabetes, cardiovascular disorders, and cancer, has been steadily increasing worldwide, necessitating comprehensive support services to help patients manage their conditions effectively. Moreover, the escalating costs of healthcare, particularly in terms of prescription medications and treatments, have created a significant financial strain on patients and their families. PSPs play a crucial role in mitigating these financial barriers by providing assistance programs, copay support, and other forms of financial aid. Furthermore, the shift towards patient-centric care models has highlighted the importance of personalized support and engagement, driving the demand for PSPs that can tailor their services to individual patient needs.
However, the market also faces certain restraints, such as the complexity of implementing and managing PSPs, data privacy concerns, and regulatory challenges. The need for seamless coordination among various stakeholders, including healthcare providers, payers, and pharmaceutical companies, can pose operational difficulties. Additionally, ensuring the protection of patient data and compliance with evolving healthcare regulations requires robust security measures and continuous adaptation.
Key features of the study:
- This report provides in-depth analysis of the global Patient Support Programs (PSP) market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global patient support programs (PSP) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Roche, Novartis, Pfizer, Merck & Co., Johnson & Johnson, Sanofi, AstraZeneca, GSK (GlaxoSmithKline), AbbVie, Amgen, Bayer, Eli Lilly and Company, Bristol-Myers Squibb, Takeda Pharmaceutical Company, and Biogen.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global patient support programs (PSP) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global patient support programs (PSP) market
Market Segmentation
- Service Type Insights (Revenue, USD Bn, 2020 - 2032)
- Medication Adherence Support
- Patient Education & Counseling
- Disease-Specific Care Coordination
- Remote Patient Monitoring
- Financial Assistance & Reimbursement
- Others
- Therapeutic Area Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Cardiology
- Neurology
- Immunology
- Rheumatology
- Others (Diabetes and Infectious Diseases)
- Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric
- Adult
- Geriatric
- Delivery Mode Insights (Revenue, USD Bn, 2020 - 2032)
- In-person Services
- Digital Solutions
- Hybrid Models
- Gender Insights (Revenue, USD Bn, 2020 - 2032)
- Male
- Female
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmaceutical Companies
- Biotechnology Companies
- Medical Device Companies
- Assisted Living facilities
- Healthcare Providers
- Others (Research Centers, etc.)
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Roche
- Novartis
- Pfizer
- Merck & Co.
- Johnson & Johnson
- Sanofi
- AstraZeneca
- GSK (GlaxoSmithKline)
- AbbVie
- Amgen
- Bayer
- Eli Lilly and Company
- Bristol-Myers Squibb
- Takeda Pharmaceutical Company
- Biogen
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Patient Support Programs (PSP) Market, By Service Type
- Global Patient Support Programs (PSP) Market, By Therapeutic Area
- Global Patient Support Programs (PSP) Market, By Age Group
- Global Patient Support Programs (PSP) Market, By Delivery Mode
- Global Patient Support Programs (PSP) Market, By Gender
- Global Patient Support Programs (PSP) Market, By End User
- Global Patient Support Programs (PSP) Market, By Region
3. Market Dynamics, Regulations, And Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Patient Support Programs (PSP) Market, By Service Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Medication Adherence Support
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Patient Education & Counseling
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Disease-Specific Care Coordination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Financial Assistance & Reimbursement
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Patient Support Programs (PSP) Market, By Therapeutic Area, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Rheumatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Diabetes and Infectious Diseases)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Patient Support Programs (PSP) Market, By Age Group, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Patient Support Programs (PSP) Market, By Delivery Mode, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- In-person Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Digital Solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hybrid Models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Patient Support Programs (PSP) Market, By Gender, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Patient Support Programs (PSP) Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Medical Device Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Assisted Living facilities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Healthcare Providers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Research Centers, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Patient Support Programs (PSP) Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Roche
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GSK (GlaxoSmithKline)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amgen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol-Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biogen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
샘플 요청 목록